AML16 Pilot Trial: A Phase1/2 Trial to assess the feasibility of combining Clofarabine with daunorubicin and Daunorubicin + Clofarabine with Mylotarg in older patients with Acute Myeloid Leukaemia and...

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-001588-78

AML16 Pilot Trial: A Phase1/2 Trial to assess the feasibility of combining Clofarabine with daunorubicin and Daunorubicin + Clofarabine with Mylotarg in older patients with Acute Myeloid Leukaemia and High Risk Myelodysplastic syndrome

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To assess the feasibility of combining Daunorubicin and Clofarabine and Daunorubicin + Clofarabine with Mylotarg in the treatment of Acute Myeloid Leukaemia and high risk Myelodyspalstic Syndrome in older (>60 years) patients


Critère d'inclusion

  • Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndrome

Liens